| Stereochemistry | ABSOLUTE |
| Molecular Formula | C35H46O14 |
| Molecular Weight | 690.7313 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@H](C)C[C@H](C)\C=C\C(=O)O[C@@H]1[C@@H](O)[C@]3(CCC(=C)[C@@H](OC(C)=O)[C@H](C)CC2=CC=CC=C2)O[C@@]1(C(O)=O)[C@@](O)([C@H](O3)C(O)=O)C(O)=O
InChI
InChIKey=DFKDOZMCHOGOBR-NCSQYGPNSA-N
InChI=1S/C35H46O14/c1-7-19(2)17-20(3)13-14-25(37)47-28-27(38)33(48-29(30(39)40)34(45,31(41)42)35(28,49-33)32(43)44)16-15-21(4)26(46-23(6)36)22(5)18-24-11-9-8-10-12-24/h8-14,19-20,22,26-29,38,45H,4,7,15-18H2,1-3,5-6H3,(H,39,40)(H,41,42)(H,43,44)/b14-13+/t19-,20+,22+,26+,27+,28+,29+,33-,34+,35-/m0/s1
| Molecular Formula | C35H46O14 |
| Molecular Weight | 690.7313 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 78.0 pM [Ki] | |||
| 216.0 nM [IC50] | |||
| 620.0 nM [IC50] |
